Life Molecular Imaging Boosts Neuraceq® Production to Enhance Alzheimer's Diagnostics in the Midwest Life Molecular Imaging has expanded Neuraceq® production in Decatur, IL, improving access to Alzheimer's diagnostics for patients in the Midwest.

Life Molecular Imaging Boosts Neuraceq® Production to Enhance Alzheimer's Diagnostics in the Midwest #United_States #Alzheimer's #Neuraceq #Life_Molecular_Imaging #Decatur,_IL

Life Molecular Imaging Expands Neuraceq® Production to Enhance Alzheimer's Diagnostics in California Life Molecular Imaging has enhanced its Neuraceq® production to increase access for Alzheimer's diagnostics in Southern California, including San Diego.

Life Molecular Imaging Expands Neuraceq® Production to Enhance Alzheimer's Diagnostics in California #United_States #Los_Angeles #Alzheimer's_Disease #Neuraceq #Life_Molecular_Imaging

Life Molecular Imaging Receives Orphan Drug Designation for Florbetaben in ATTR Amyloidosis Diagnosis Life Molecular Imaging has been granted orphan drug status by the European Commission for florbetaben (18F), enhancing its role in ATTR amyloidosis diagnosis and treatment.

Life Molecular Imaging Receives Orphan Drug Designation for Florbetaben in ATTR Amyloidosis Diagnosis #Germany #Berlin #Life_Molecular_Imaging #Florbetaben #ATTR_Amyloidosis

European Commission Approves Orphan Drug Status for Florbetaben, Aiding ATTR Amyloidosis Diagnosis Florbetaben (18F) has received orphan drug designation from the European Commission for the diagnosis of ATTR amyloidosis, enhancing early detection and treatment.

European Commission Approves Orphan Drug Status for Florbetaben, Aiding ATTR Amyloidosis Diagnosis #Germany #Berlin #Life_Molecular_Imaging #Florbetaben #ATTR_Amyloidosis

Life Molecular Imaging and SOFIE Launch Neuraceq® to Improve Alzheimer's Care in Albany, NY Life Molecular Imaging and SOFIE expand partnership to make Neuraceq® available in Albany, enhancing access for Alzheimer's diagnostics.

Life Molecular Imaging and SOFIE Launch Neuraceq® to Improve Alzheimer's Care in Albany, NY #USA #Albany #Neuraceq #SOFIE #Life_Molecular_Imaging

Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology Life Molecular Imaging has secured $2.16 million from the Alzheimer's Drug Discovery Foundation to enhance PET imaging research for Alzheimer’s disease neuroinflammation over three years.

Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology #United_States #Boston #Life_Molecular_Imaging #Alzheimer’s_Drug_Discovery_Foundation #PET_imaging

Life Molecular Imaging Expands Neuraceq® Availability Through Strategic Partnership in Salt Lake City Life Molecular Imaging has launched Neuraceq® in Salt Lake City to improve access to essential PET imaging for Alzheimer’s evaluation, enhancing patient care significantly.

Life Molecular Imaging Expands Neuraceq® Availability Through Strategic Partnership in Salt Lake City #USA #Salt_Lake_City #Neuraceq #Life_Molecular_Imaging #PharmaLogic

Life Molecular Imaging Receives FDA's Fast Track for [18F]Florbetaben in Cardiac Amyloidosis Diagnosis Life Molecular Imaging announces Fast Track designation from FDA for [18F]Florbetaben, enhancing cardiac AL and ATTR amyloidosis diagnosis.

Life Molecular Imaging Receives FDA's Fast Track for [18F]Florbetaben in Cardiac Amyloidosis Diagnosis #United_States #Boston #FDA_Fast_Track #Life_Molecular_Imaging #Florbetaben